We analyze noise-free headlines and recent hype associated with CVS Health Corporation which may create opportunities for some arbitrage if properly timed. With CVS Health hype-based prediction module you can estimate the value of CVS Health Corporation from the prospective of CVS Health response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on CVS Health over a specific investment horizon. Check also CVS Health Basic Forecasting Models to cross-verify your projections.
On 16 of October CVS Health is traded for 65.64. The entity has historical hype elasticity of -0.16 and average elasticity to hype of competition of -0.2. CVS Health Corporation is estimated to decline in value after the next headline with price expected to drop to 64.68. The average volatility of media hype impact on the company stock price is about 258.06%. The price depreciation on the next news is expected to be -0.23% where as daily expected return is currently at 0.26%. The volatility of related hype on CVS Health is about 209.06% with expected price after next announcement by competition of 65.44. About 84.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Health has Price/Earnings To Growth (PEG) ratio of 2.68. The entity last dividend was issued on 2019-07-24. The firm had 2:1 split on 2005-06-07. Considering 30-days investment horizon, the next estimated press release will be in about 8 days. Check also CVS Health Basic Forecasting Models to cross-verify your projections.